SOLOIST WHF：Sotagliflozin in Patients with Diabetes and Recent ...
Sotagliflozin in Patients with Diabetes and Recent ...
由DLBhatt著作·2021·被引用1562次—TheSOLOIST-WHFtrialwasaphase3,double-blind,randomized,placebo-controlledtrial.Sanofiwastheoriginalsponsor;sponsorshipwas ...。其他文章還包含有：「NCT03521934」、「EffectofSotagliflozinonCardiovascularEventsinPatients...」、「EffectofSotagliflozinonEarlyMortalityandHeartFailure...」、「SOLOIST」
查看更多 離開網站
NCT03521934
https://clinicaltrials.gov
沒有這個頁面的資訊。
Effect of Sotagliflozin on Cardiovascular Events in Patients ...
https://www.acc.org
The SOLOIST-WHF trial showed that sotagliflozin has salutary effects on CV outcomes among patients with T2DM and HF.
Effect of Sotagliflozin on Early Mortality and Heart Failure ...
https://www.jacc.org
In the SOLOIST-WHF trial primary analysis, the administration of sotagliflozin resulted in a significantly lower number of cardiovascular deaths ...
SOLOIST
https://www.inpefahcp.com
INPEFA is indicated to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults.